ASD-EXP and NT-EXP for Autism

University of Alabama, Tuscaloosa, AL
Autism+9 More ConditionsVisualizing and Verbalizing for Language comprehension and Thinking - Behavioral
7 - 13
All Sexes

Study Summary

This trial will test the impact of a reading intervention program on children with ASD to see if it changes the neurobiological mechanisms underlying reading comprehension deficits.

Eligible Conditions
  • Autism
  • Autism Spectrum Disorder (ASD)
  • Autism Spectrum Disorder
  • Autism Spectrum Disorder with Neuropsychiatric Symptoms (ASD-NPS)
  • Dyslexia

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
Phase < 1

Study Objectives

2 Primary · 1 Secondary · Reporting Duration: 10-12 weeks

10-12 weeks
Change in reading comprehension
Behavior Therapy

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

1 of 2
1 of 2

Active Control

Experimental Treatment

200 Total Participants · 2 Treatment Groups

Primary Treatment: ASD-EXP and NT-EXP · No Placebo Group · Phase < 1

Experimental Group · 1 Intervention: Visualizing and Verbalizing for Language comprehension and Thinking · Intervention Types: Behavioral
ASD-WLC and NTNoIntervention Group · 1 Intervention: ASD-WLC and NT · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 10-12 weeks

Who is running the clinical trial?

University of Alabama at BirminghamOTHER
1,475 Previous Clinical Trials
2,246,027 Total Patients Enrolled
University of Alabama, TuscaloosaLead Sponsor
35 Previous Clinical Trials
18,180 Total Patients Enrolled

Eligibility Criteria

Age 7 - 13 · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have not taken antipsychotic medication for at least one month.
Participants who have difficulty understanding what they read, specifically in the group with autism, will be included.
You have been diagnosed with Autism Spectrum Disorder (ASD) according to the DSM-V criteria.

Frequently Asked Questions

Does the protocol for this clinical trial allow those of advanced age to participate?

"Based on the parameters of this study, participants must fall between 7 and 13 years old." - Anonymous Online Contributor

Unverified Answer

How many individuals have registered to partake in this experiment?

"Affirmative. The clinical trial data found on shows that the research is actively seeking participants, with a starting date of January 10th 2019 and most recent update occurring on September 30th 2022. 200 people are required from 1 centre to complete the study." - Anonymous Online Contributor

Unverified Answer

Are there still openings for participants in this experiment?

"According to the records on, this medical experiment is currently seeking patients and has been since January 10th 2019. The last update was made on September 30th 2022." - Anonymous Online Contributor

Unverified Answer

What qualifications must an individual possess to be eligible for this investigation?

"This clinical study aims to recruit two hundred children, ranging from 7-13 years of age and diagnosed with autism spectrum disorder. Furthermore, participants must adhere to several criteria in order for eligibility: no stimulants within 24 hours prior, absence of antipsychotics treatment for one month minimum, lack of antiepileptics/convulsants use over the last week; meet American Psychiatric Association's DSM-V standards (2013); Full Scale IQs score higher than 70 and possess similar reading comprehension difficulties as ASD patients but featuring average decoding complemented by below standard reading understanding." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.